Shenyang Xingqi Pharmaceutical Co., Ltd. (300573) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shenyang Xingqi Pharmaceutical Co., Ltd.

Why is Shenyang Xingqi Pharmaceutical Co., Ltd. ?

With a growth in Net Profit of 117.45%, the company declared Outstanding results in Sep 25

OPERATING CASH FLOW(Y) Highest at CNY 635.84 MM
ROCE(HY) Highest at 37.08%
INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost

With ROE of 28.64%, it has a very attractive valuation with a 9.15 Price to Book Value

Over the past year, while the stock has generated a return of 12.48%, its profits have risen by 56.6% ; the PEG ratio of the company is 2.8
At the current price, the company has a high dividend yield of 1.9

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Shenyang Xingqi Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shenyang Xingqi Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shenyang Xingqi Pharmaceutical Co., Ltd.

15.08%

-1.04

50.71%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

31.96%

EBIT Growth (5y)

59.29%

EBIT to Interest (avg)

91.89

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.18

Sales to Capital Employed (avg)

0.97

Tax Ratio

15.39%

Dividend Payout Ratio

55.32%

Pledged Shares

Institutional Holding

ROCE (avg)

25.75%

ROE (avg)

17.53%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

9.15

EV to EBIT

27.51

EV to EBITDA

23.24

EV to Capital Employed

10.09

EV to Sales

7.28

PEG Ratio

2.82

Dividend Yield

1.86%

ROCE (Latest)

36.69%

ROE (Latest)

28.64%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Sideways

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

31What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 635.84 MM

ROCE(HY)

Highest at 37.08%

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by -6.94% (YoY

NET SALES(Q)

Highest at CNY 740.99 MM

OPERATING PROFIT(Q)

Highest at CNY 302.08 MM

OPERATING PROFIT MARGIN(Q)

Highest at 40.77 %

PRE-TAX PROFIT(Q)

Highest at CNY 304.06 MM

NET PROFIT(Q)

Highest at CNY 264.08 MM

EPS(Q)

Highest at CNY 1.08

-1What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -13.22 %

Here's what is working for Shenyang Xingqi Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 635.84 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

At CNY 304.06 MM has Grown at 121.08%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 264.08 MM has Grown at 117.45%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

Highest at CNY 740.99 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 740.99 MM has Grown at 35.34%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 302.08 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at 40.77 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at CNY 304.06 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 264.08 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 1.08

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -6.94% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shenyang Xingqi Pharmaceutical Co., Ltd.

Debt-Equity Ratio

Highest at -13.22 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio